Lumicks BV, of Amsterdam, the Netherlands, has partnered with Astrazeneca plc, of Cambridge, U.K., and the University of Cambridge biochemistry department to form the Center of Excellence for Dynamic Single-Molecule Analysis for Accelerated Drug Discovery and Biology, the first of its kind worldwide.